Skip to main content

Study M221

Study name

Czeh B 2001

Title

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine

Overall design

The present study investigated the effect of tianeptine, a modified tricyclic antidepressant, in the chronic psychosocial stress model of adult male tree shrews (Tupaia belangeri), a model with high validity for research on the pathophysiology of major depression. Animals were divided into the following 4 groups (n = 6 in each group): (1) control group, (2) stress group (daily psychosocial conflict stress), (3) tianeptine group (tianeptine treatment at the dose of 50 mg/kg), and (4) stress + tianeptine group (daily psychosocial conflict stress plus tianeptine treatment at the dose of 50 mg/kg). The psychosocial conflict stress procedure lasted for 5 weeks, and tianeptine was administered via tap water during the last 4 weeks of the model building period. At the end of the experiment, all animals underwent proton MRS measurements to evaluate in vivo brain metabolite concentrations of N-acetyl-aspartate, creatine and phosphocreatine, choline-containing compounds, and myo-inositol. Metabolite quantification was reported relative to brain water concentration.

Study Type

Type1;

Type2;

Type3;

Data available

Unavailable

Organism

Non-human primate; Tree shrew;

Categories of depression

Healthy individuals; Healthy individuals; Healthy individuals;

Animal model; Other animal model; Other animal model;

Criteria for depression

Not reported

Sample size

24

Tissue

Central; Brain; Brain;

Platform

MRS; MRS: 2.35 T MRBR 4.7/400 mm magnet (Magnex Scientific, Abingdon, England);

PMID

11675510

DOI

10.1073/pnas.211427898

Citation

Czeh B, Michaelis T, Watanabe T, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A 2001;98(22):12796-801.

Metabolite

N-Acetyl-L-aspartic acid;

Choline-containing compounds;

Creatine and Phosphocreatine;